机译:ZD2肽靶向GD(HP-DO3A)的优化,用于MRI的前列腺癌的检测和风险分层
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
Molecular Theranostics Cleveland;
Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering Case Western Reserve University;
cancer detection and risk-stratification; EDB fibronectin; prostate cancer; targeted MRI contrast agent; ZD2 peptide;
机译:ZD2肽靶向GD(HP-DO3A)的优化,用于MRI的前列腺癌的检测和风险分层
机译:MRI融合靶向癌症前列腺活检和前列腺特异性抗原密度和前列腺健康指数检测东南亚男性临床显着的前列腺癌的作用
机译:作者的回复:Heedvig Hricak的Hebert Alberto Vargas。针对磁共振成像的前列腺活检:现在是开始的时候了。 Eur Urol 2013; 64:553-4:START:开展多学科工作以定义以MRI为目标的活检在检测临床上重要的前列腺癌中的作用的开端
机译:评估靶前列腺癌放射治疗前列腺MRI可变形登记的准确性
机译:肽受体靶向诊断和治疗放射性药物前列腺癌的合成与临床前评价
机译:ZD2肽靶向Gd(HP-DO3A)的优化MRI对前列腺癌的检测和风险分层
机译:ZD2肽靶向GD(HP-DO3A)的优化,用于患有MRI的前列腺癌的检测和风险分层
机译:前列腺癌靶向肽的优化和表征